Compare Exelixis Inc. Common Stock (EXEL) vs Global E Online Ltd (GLBE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelixis Inc. Common Stock vs Global E Online Ltd — how do they compare? Exelixis Inc. Common Stock trades at $59.11 (market cap $14.62B), while Global E Online Ltd trades at $40.26 (market cap $6.75B). The key difference: Exelixis Inc. Common Stock is far larger — about 2.2× Global E Online Ltd's market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, Global E Online Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and Global E Online Ltd for 21 Days on average.
| EXEL | GLBE | |
|---|---|---|
Market Cap | $14.62B | $6.75B |
Volume | 2,684,957 | 1,468,708 |
Sector | Health | Consumer Cyclical |
52-Week High | $59.13 | $42.36 |
52-Week Low | $34.54 | $27.54 |
Typical Hold Time | 0 Days | 21 Days |
Enterprise Value | $13.95B | $6.24B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GLBE trades at $38.96, up 0.67% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong Q2 2026 earnings, beating EPS estimates, and raised its full-year 2026 outlook. Revenue grew 39% year-over-year in Q2, with an adjusted EBITDA margin expansion to 20.9%. Analyst consensus is strongly bullish with a $48.86 price target, though recent insider selling and a high P/E ratio of 45.65 warrant attention.
The outlook for GLBE is positive based on robust revenue growth and raised guidance, but risks include high valuation multiples and insider selling activity. The stock presents a growth opportunity if execution continues, yet investors should weigh the premium valuation against future earnings potential amid competitive e-commerce markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Exelixis Inc. Common Stock
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →About Global E Online Ltd
Global-e provides a platform for cross-border e-commerce, helping retailers increase international sales by localizing the shopping experience for consumers in over 200 destinations worldwide.
Read more on GLBE →
